Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial

Abiu Sempere, Lambert Assoumou, Ana González-Cordón, Laura Waters, Stefano Rusconi, Pere Domingo, Mark Gompels, Stephane de Wit, François Raffi, Christoph Stephan, Mar Masiá, Jürgen Rockstroh, Christine Katlama, Georg M N Behrens, Graeme Moyle, Margaret Johnson, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Eric Florence, Stefan Esser, José Gatell, Anton Pozniak, Esteban Martínez, Unknown, Linos Vandekerckhove, Els Caluwé, Stephane De Wit, Coca Necsoi, Eric Florence, and Maartje Van Frankenhuijsen

Open source

DOI
10.1093/cid/ciad297
Published
2023-05-19
Container
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciad297,
  title = {Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial},
  author = {Abiu Sempere and Lambert Assoumou and Ana González-Cordón and Laura Waters and Stefano Rusconi and Pere Domingo and Mark Gompels and Stephane de Wit and François Raffi and Christoph Stephan and Mar Masiá and Jürgen Rockstroh and Christine Katlama and Georg M N Behrens and Graeme Moyle and Margaret Johnson and Julie Fox and Hans-Jürgen Stellbrink and Giovanni Guaraldi and Eric Florence and Stefan Esser and José Gatell and Anton Pozniak and Esteban Martínez and Unknown and Linos Vandekerckhove and Els Caluwé and Stephane De Wit and Coca Necsoi and Eric Florence and and Maartje Van Frankenhuijsen},
  year = {2023},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciad297},
  url = {https://doi.org/10.1093/cid/ciad297}
}

RIS

TY  - JOUR
TI  - Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
AU  - Abiu Sempere
AU  - Lambert Assoumou
AU  - Ana González-Cordón
AU  - Laura Waters
AU  - Stefano Rusconi
AU  - Pere Domingo
AU  - Mark Gompels
AU  - Stephane de Wit
AU  - François Raffi
AU  - Christoph Stephan
AU  - Mar Masiá
AU  - Jürgen Rockstroh
AU  - Christine Katlama
AU  - Georg M N Behrens
AU  - Graeme Moyle
AU  - Margaret Johnson
AU  - Julie Fox
AU  - Hans-Jürgen Stellbrink
AU  - Giovanni Guaraldi
AU  - Eric Florence
AU  - Stefan Esser
AU  - José Gatell
AU  - Anton Pozniak
AU  - Esteban Martínez
AU  - Unknown
AU  - Linos Vandekerckhove
AU  - Els Caluwé
AU  - Stephane De Wit
AU  - Coca Necsoi
AU  - Eric Florence
AU  - and Maartje Van Frankenhuijsen
PY  - 2023
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciad297
UR  - https://doi.org/10.1093/cid/ciad297
ER  -

APA

Sempere, A., Assoumou, L., González-Cordón, A., Waters, L., Rusconi, S., Domingo, P., Gompels, M., Wit, S. D., Raffi, F., Stephan, C., Masiá, M., Rockstroh, J., Katlama, C., Behrens, G. M. N., Moyle, G., Johnson, M., Fox, J., Stellbrink, H., Guaraldi, G., Florence, E., Esser, S., Gatell, J., Pozniak, A., Martínez, E., Unknown, Vandekerckhove, L., Caluwé, E., Wit, S. D., Necsoi, C., Florence, E., & Frankenhuijsen, A. M. V. (2023). Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad297

Source records